Interestingly, and vice versa, treatment of IPF fibroblasts with HDAC inhibitors resulted in the reduction of profibrotic genes, such as COL3A1, in association with marked chromatin alterations [164,165,167]. This evidence concerns the gene HDAC9 and idiopathic pulmonary fibrosis.